Compare CUE & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUE | IH |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.5M | 70.5M |
| IPO Year | 2017 | 2020 |
| Metric | CUE | IH |
|---|---|---|
| Price | $28.26 | $1.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | ★ 76.1K | 7.2K |
| Earning Date | 05-13-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 5.88% |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $1.33 |
| 52 Week High | $41.42 | $3.60 |
| Indicator | CUE | IH |
|---|---|---|
| Relative Strength Index (RSI) | 53.98 | 43.86 |
| Support Level | $0.24 | N/A |
| Resistance Level | $32.82 | $1.53 |
| Average True Range (ATR) | 3.73 | 0.06 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 42.89 | 40.02 |
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.